
Well-child care follows the AAP Bright Futures periodicity schedule: visits at 3 to 5 days, 1, 2, 4, 6, 9, 12, 15, 18, 24 and 30 months, then yearly, with developmental screening at 9, 18 and 30 months and autism screening at 18 and 24 months. Milestones are judged against the CDC 2022 checklists, which list what most children (75 percent or more) do by each age, so a missed milestone calls for screening, not waiting. Vaccines follow the routine childhood schedule; the CDC 2026 revision was suspended by a federal court in 2026, so confirm the current version before practice.
A well-child visit on the FNP exam is a fixed package: the right visit age, the screenings due at that age, a milestone check against the CDC 2022 checklist, anticipatory guidance and the vaccines due. The AAP Bright Futures periodicity schedule sets the visit ages and the screening calendar, the CDC milestones (revised in 2022 to the age at which at least 75 percent of children achieve each skill) define what to expect, and the routine childhood immunization schedule sets the vaccines. Most exam questions turn on one number: the age a screen is due, the age a milestone should be present, or the minimum age or interval for a vaccine.
Bright Futures recommends a prenatal visit, a newborn evaluation, then visits at 3 to 5 days, by 1 month, and at 2, 4, 6, 9, 12, 15, 18, 24 and 30 months, followed by annual visits from 3 through 21 years. The 3 to 5 day visit exists for weight, feeding and jaundice: it is where the provider checks weight loss from birth weight, breastfeeding adequacy and bilirubin risk.
Every visit includes history, measurements, developmental surveillance, a physical examination, anticipatory guidance and immunization review. Growth is plotted at every visit: weight-for-length before age 2 and body mass index from age 2. Blood pressure is measured annually from age 3, and earlier in children with risk conditions such as prematurity, congenital heart disease or kidney disease.
The periodicity schedule distinguishes universal screening (done for every child at that age) from risk assessment (screen only if the risk questions are positive). The table lists the universal items the exam tests most often.
| Screen | Age(s) | Notes |
|---|---|---|
| Newborn blood spot, hearing, critical congenital heart disease (pulse oximetry), bilirubin | Newborn period | Repeat or confirm per state program and nursery results |
| Maternal (postpartum) depression | 1, 2, 4 and 6 month visits | Screens the parent at the child's visit |
| General developmental screening (standardized tool) | 9, 18 and 30 months | Also any time surveillance raises concern |
| Autism-specific screening | 18 and 24 months | For example the M-CHAT-R/F |
| Anemia (hemoglobin or hematocrit) | 12 months | Risk assessment at other ages |
| Lead | Risk assessment from 6 months; blood lead at 12 and 24 months when at risk or required | Medicaid enrollees require testing at 12 and 24 months |
| Fluoride varnish | From eruption of the first tooth, every 3 to 6 months by caries risk, through age 5 | Oral fluoride supplementation if water is deficient |
| Vision | Instrument-based screening from 12 months to 3 years when appropriate; acuity at 3, 4, 5, 6, 8, 10, 12 and 15 years | Instrument screening is an option through age 5 |
| Hearing | Audiometry at 4, 5, 6, 8 and 10 years; once at 11 to 14, 15 to 17 and 18 to 21 years | Adolescent screening includes high frequencies |
| Dyslipidemia | Once at 9 to 11 years and once at 17 to 21 years | Risk assessment at 2, 4, 6, 8 years and in adolescence |
| Depression and suicide risk | Annually from 12 years | Suicide risk screening was added to the adolescent depression screen |
| Tobacco, alcohol and drug use | Risk assessment annually from 11 years | Naloxone guidance added in 2024 |
| HIV | Once between 15 and 21 years | Retest annually or more often when at increased risk |
| Hepatitis C | At least once from 18 years | Reassess annually when risk persists |
| Sudden cardiac arrest or death risk | Assessment from 11 to 21 years | Family history, exertional syncope or chest pain |
A recurring exam trap is to offer the autism screen at 9 months or the general developmental screen at 24 months. Remember the pattern: general developmental screening at 9, 18 and 30 months, autism at 18 and 24 months, so the 18-month visit carries both.
The 2022 revision by the AAP and CDC (Zubler and colleagues) changed what a milestone means. Each listed skill is one that at least 75 percent of children show by that age. A child who is missing one is therefore already behind most peers, and the guidance is to screen and refer rather than wait and see. The revision also added checklists at 15 and 30 months, so every Bright Futures visit from 2 months to 5 years now has one. Some milestones moved: crawling was removed because many children skip it, and several skills now appear at a later checklist than in older material, which is why older study guides may cite earlier ages.
| Age | Gross and fine motor | Language and social |
|---|---|---|
| 2 months | Holds head up when on tummy; opens hands briefly | Smiles when talked to; makes sounds other than crying |
| 4 months | Holds head steady without support when held; brings hands to mouth | Coos; turns head toward a voice; smiles to get attention |
| 6 months | Rolls from tummy to back; pushes up on straight arms; leans on hands when sitting | Laughs; takes turns making sounds; knows familiar people |
| 9 months | Sits without support; gets to a sitting position alone; moves objects hand to hand | Babbles "mamamama" or "babababa"; looks when name is called; shows stranger anxiety |
| 12 months | Pulls to stand; walks holding furniture (cruising); pincer grasp | Waves bye-bye; says "mama" or "dada" or a special name; understands "no" |
| 15 months | Takes a few steps alone; feeds self with fingers | Tries one or two words besides "mama" or "dada"; points to ask for something |
| 18 months | Walks without holding on; scribbles; drinks from an open cup | Tries three or more words; follows one-step directions without gestures |
| 2 years | Kicks a ball; runs; walks up a few stairs; eats with a spoon | Says at least two words together; points to two body parts and to pictures in a book |
| 30 months | Jumps off the ground with both feet; twists doorknobs | Says about 50 words; uses two or more words with an action word |
| 3 years | Strings items such as beads; uses a fork | Converses with at least two back-and-forth exchanges; says first name; draws a circle when shown |
| 4 years | Catches a large ball most of the time; unbuttons some buttons | Says sentences of four or more words; draws a person with three or more body parts |
| 5 years | Hops on one foot; buttons some buttons | Tells a story with at least two events; counts to 10; writes some letters |
A missing milestone, a parent concern or a positive screen leads to three parallel actions: a standardized screening tool if one has not just been done, referral to early intervention (Part C, birth to 3 years) or the school district (Part B, 3 years and older) without waiting for a diagnosis, and medical evaluation, including audiology for any speech delay. Loss of a previously acquired skill at any age is a red flag that needs prompt evaluation. Prematurity is handled by using the corrected age for milestones until about 2 years.
The following routine series reflects the childhood schedule that CDC posted before the 2026 revision and that the AAP continues to endorse. Exact minimum ages, intervals and catch-up rules live in the schedule notes and should be checked there.
| Vaccine | Routine ages | High-yield detail |
|---|---|---|
| Hepatitis B | Birth, 1 to 2 months, 6 to 18 months | Infant of an HBsAg-positive mother: vaccine plus HBIG within 12 hours of birth |
| Rotavirus (oral) | 2, 4 (and 6) months | Do not start at 15 weeks or later; finish by 8 months; contraindicated with SCID or prior intussusception |
| DTaP | 2, 4, 6, 15 to 18 months, 4 to 6 years | Five doses; Tdap at 11 to 12 years |
| Hib | 2, 4, (6), 12 to 15 months | Third infant dose depends on product |
| Pneumococcal conjugate | 2, 4, 6, 12 to 15 months | PCV15 or PCV20 |
| Inactivated polio | 2, 4, 6 to 18 months, 4 to 6 years | Four doses |
| Influenza | Yearly from 6 months | Two doses four weeks apart in the first season for children younger than 9 years |
| MMR and varicella | 12 to 15 months, 4 to 6 years | Live vaccines: same day or at least 28 days apart |
| Hepatitis A | Two doses from 12 to 23 months, 6 months apart | |
| Tdap, MenACWY, HPV | 11 to 12 years; MenACWY booster at 16 | HPV can start at 9; two doses if started before 15, three if started at 15 or later or if immunocompromised |
| RSV monoclonal antibody | One dose for infants younger than 8 months entering their first RSV season | Not needed when the mother was vaccinated at least 14 days before birth; second-season dose for high-risk children 8 to 19 months |
Contraindications and precautions are tested as often as ages. Anaphylaxis to a prior dose or component is a contraindication to that vaccine. Live vaccines (MMR, varicella, rotavirus, intranasal influenza) are withheld in severe immunodeficiency and pregnancy. A moderate or severe acute illness is a precaution. Mild illness, low-grade fever, antibiotic use, prematurity, breastfeeding, a pregnant household contact and egg allergy are not reasons to delay.
In January 2026 an HHS directive produced a revised CDC childhood schedule that moved hepatitis A, the hepatitis B birth dose for infants of HBsAg-negative mothers, rotavirus, influenza, COVID-19 and MenACWY from routine recommendation to risk-based or shared clinical decision-making categories. The AAP rejected the revision and kept recommending the prior harmonized schedule. In American Academy of Pediatrics v Kennedy, a federal district court in Massachusetts suspended the 2026 schedule and reinstated the earlier version; the government appealed, and no appellate ruling had been issued as of September 2026. Because the legal status may change, confirm in the current guideline which version CDC is posting before advising a family. Certification exams are built from established content and are written to the routine schedule above.
Refer or escalate when there is loss of skills, a positive autism screen (diagnostic evaluation plus early intervention at the same time), any speech delay without a recent audiology evaluation, crossing two or more major percentile lines on the growth curve, an elevated blood lead level per the CDC reference value, persistent hypertension, a family history of sudden cardiac death before age 50, or a positive suicide risk screen, which requires same-day safety assessment.
An 18-month-old boy is brought in for a well visit. He walks well, scribbles and drinks from an open cup. His mother reports that he says "mama" and "ball" but no other words, does not point to show her things and rarely looks up when his name is called. He had otitis media twice last winter. Vaccines are up to date except the visit's scheduled doses, and he has a mild cold with a temperature of 99.5 F today. Which action is most appropriate?
Answer: B. At 18 months the CDC checklist expects three or more words and the Bright Futures schedule calls for both general developmental screening and autism screening, so this child needs both tools, early intervention referral and an audiology evaluation given the delay and ear infection history. Option A is wrong twice: a mild cold with low-grade fever is not a reason to defer vaccines, and "wait and see" ignores a missed milestone. Option C substitutes labs for the screening that is due and delays action. Option D is wrong because early intervention referral should happen at the same time as diagnostic evaluation, not after it.
Common follow-up questions on Pediatrics & Women's Health (FNP).
Surveillance happens at every well visit and uses the milestone checklist, parent concerns and observation. Screening uses a validated standardized tool and is scheduled at 9, 18 and 30 months, plus autism-specific screening at 18 and 24 months, or any time surveillance raises a concern.
The earlier checklists used the age at which about half of children reach a skill, which encouraged waiting. The 2022 revision moved each milestone to the age when at least 75 percent of children reach it and added 15 and 30 month checklists, so a missing milestone is a reason to act.
No. Mild acute illness with or without low-grade fever, current antibiotic use and egg allergy are not contraindications. A moderate or severe acute illness is a precaution, and anaphylaxis to a prior dose or a vaccine component is a contraindication.
As of September 2026 a federal court had suspended the 2026 CDC schedule and reinstated the prior version, which the AAP endorses, and the government had appealed. Check the CDC and AAP schedule pages on the day of practice; board items are written to the routine schedule.
FNP and AGNP board questions written as primary-care cases, with guideline-based explanations, for the AANP and ANCC exams. Create a free account and pick your track.
Create Free Account →